Rallybio Corporation
RLYB
$0.535
$0.0715.05%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.44M | -11.04M | -11.47M | -16.24M | -19.03M |
| Total Depreciation and Amortization | 28.00K | 30.00K | 32.00K | 34.00K | 35.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.26M | 2.08M | 2.32M | 1.99M | 2.23M |
| Change in Net Operating Assets | -3.05M | -925.00K | -4.43M | 3.80M | 1.30M |
| Cash from Operations | -10.21M | -9.86M | -13.55M | -10.42M | -15.46M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 11.08M | -1.57M | 22.21M | 2.60M | 10.26M |
| Cash from Investing | 11.08M | -1.57M | 22.21M | 2.60M | 10.26M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 18.00K | 0.00 | 5.45M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | -11.00K | -257.00K | -- |
| Cash from Financing | -- | 18.00K | -11.00K | 5.19M | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 876.00K | -11.42M | 8.65M | -2.63M | -5.19M |